Related Experiment Video
Updated: Jul 18, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Novel therapies for acute ischemic stroke.
Ronen R Leker1, Roni Eichel, Guy Rafaeli
1Department of Neurology, Ginges Center for Neurogenetics, Scheinberg Cerebrovascular Research Laboratory, Hadassah University Hospital, Hebrew University-Hadassah Medical School, Jerusalem, Israel. leker@cc.huji.ac.il
The Israel Medical Association Journal : IMAJ
|December 22, 2006
Summary
Novel therapies are urgently needed for acute ischemic stroke (AIS), a leading cause of death and disability. Current treatments like tissue plasminogen activator have limitations, driving research into cutting-edge neuroprotective strategies.
Area of Science:
- Neurology
- Neuroscience
- Pharmacology
Background:
- Acute ischemic stroke (AIS) is a major global health challenge, causing significant mortality and long-term disability.
- Existing treatments, such as tissue plasminogen activator, have narrow therapeutic windows and limited patient eligibility.
- Despite extensive research, no single neuroprotective drug has proven effective in clinical trials for AIS.
Purpose of the Study:
- To review and highlight novel and cutting-edge therapeutic strategies for acute ischemic stroke.
- To address the unmet need for more effective treatments beyond current standards of care.
- To explore potential neuroprotective agents targeting mechanisms of cerebral ischemia.
Main Methods:
- Literature review of recent advancements in acute ischemic stroke therapies.
- Survey of emerging neuroprotective drug candidates and treatment modalities.
- Analysis of preclinical and early clinical data on novel therapeutic approaches.
Main Results:
- Identification of several promising therapeutic avenues beyond traditional revascularization.
- Discussion of strategies aimed at salvaging the ischemic penumbra.
- Highlighting the potential of novel agents to overcome limitations of current AIS treatments.
Conclusions:
- Novel therapeutic strategies are essential to improve outcomes for acute ischemic stroke patients.
- Emerging treatments show promise in addressing the complex pathophysiology of cerebral ischemia.
- Continued research and clinical trials are crucial for developing effective neuroprotective therapies for AIS.
Related Concept Videos
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...